Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Since COVID-19 onset, admissions for MI are down, mortality rates are up
Key clinical point: The COVID-19 pandemic was associated with a reduction in heart attack admissions and an increase in mortality.
Major finding: Relative to prepandemic outcomes, observed mortality for ST-segment elevation MI increased by roughly 100%.
Data source: A cross-sectional retrospective study.
Disclosures: The senior investigator, Dr. Gluckman, reported no potential conflicts of interest.
Citation:
Gluckman TJ et al. JAMA Cardiol. 2020 Aug 7. doi: 10.1001/jamacardio.2020.3629.